studi
object
investig
efficaci
safeti
profil
corticosteroid
therapi
sever
acut
respiratori
syndrom
sar
patient
design
four
hundr
one
sar
case
treat
guangzhou
china
decemb
june
fulfil
diagnost
criteria
issu
world
health
organ
confirm
identif
sar
among
diagnosi
critic
sar
defin
criteria
sar
guidelin
incorpor
low
oxygen
index
oi
mm
hg
data
patient
retriev
databas
retrospect
analyz
logist
regress
cox
regress
effect
corticosteroid
therapi
death
hospit
day
complic
present
result
among
sar
patient
studi
noncrit
patient
receiv
corticosteroid
mean
daili
dose
mg
sd
surviv
diseas
critic
patient
receiv
corticosteroid
mean
daili
dose
mg
die
analysi
confirm
case
show
benefit
corticosteroid
death
rate
hospit
day
howev
focus
critic
sar
case
factor
correl
end
point
indic
univari
analysi
includ
use
corticosteroid
age
rigor
onset
secondari
respiratori
infect
pulmonari
rale
grade
oi
use
invas
ventil
adjust
possibl
confound
treatment
corticosteroid
shown
contribut
lower
overal
mortal
instant
mortal
shorter
hospit
stay
p
incid
complic
significantli
associ
need
invas
ventil
use
corticosteroid
conclus
guangzhou
retrospect
studi
reveal
proper
use
corticosteroid
confirm
critic
sar
result
lower
mortal
shorter
hospit
stay
associ
signific
secondari
lower
respiratori
infect
complic
avail
glucocorticosteroid
administr
acut
lung
injuri
ali
ard
aris
critic
sar
remain
controversi
ali
ard
aris
etiolog
mani
studi
look
use
corticosteroid
sar
manag
term
efficaci
durat
dose
sever
advers
event
howev
investig
need
character
treatment
efficaci
safeti
profil
steroid
condit
author
impli
largedos
steroid
indic
earli
phase
diagnosi
made
prevent
deterior
other
thought
largedos
therapi
advis
although
steroid
could
help
open
clinic
trial
also
demonstr
puls
steroid
therapi
could
reduc
mortal
without
associ
increas
rate
lifethreaten
complic
unfortun
studi
selfcontrol
base
therefor
convinc
due
lack
control
group
studi
design
natur
histori
progress
sar
yet
unclear
time
studi
guangzhou
guangdong
provinc
china
citi
sar
epidem
first
broke
condit
manag
communityacquir
pneumonia
sar
coronaviru
sarscov
confirm
pathogen
complic
ali
patient
administ
steroid
empir
base
treatment
aliard
aris
otherwis
avail
evid
guidelin
time
arriv
efficaci
safeti
profil
steroid
therapi
review
recent
data
studi
set
databas
guangzhou
sar
case
evalu
sarsrel
steroid
therapi
retrospect
studi
expect
character
efficaci
safeti
profil
steroid
therapi
guangzhou
multivari
analysi
decemb
june
regist
case
clinic
diagnos
sar
admit
hospit
guangzhou
china
among
screen
strictli
fulfil
criteria
issu
world
health
organ
confirm
identif
sar
also
least
one
follow
condit
seroconvers
fourfold
rise
higher
sarsigg
day
later
onset
posit
polymeras
chain
reaction
pcr
result
sarscov
confirm
two
laboratori
acut
phase
four
hundr
one
patient
met
criteria
enrol
studi
databas
setup
case
record
sar
patient
review
investig
input
databas
excel
microsoft
redmond
wa
statist
design
uniform
field
includ
patient
demograph
data
contact
histori
etiolog
investig
sarsigg
sarspcr
underli
diseas
symptom
sign
chest
radiographi
laboratori
investig
complic
medic
intervent
prognosi
caus
death
evalu
chest
radiographi
side
lung
field
divid
zone
anatom
third
upper
lower
later
medial
part
zone
total
side
zone
score
base
degre
pulmonari
opac
hazi
medium
densiti
high
densiti
consolid
sum
subscor
defin
total
score
pulmonari
abnorm
radiographi
total
score
pulmonari
abnorm
compar
previou
chest
radiograph
determin
tendenc
chest
radiographi
abnorm
tendenc
chest
radiographi
abnorm
classifi
progress
increas
total
score
stabl
chang
total
score
improv
reduct
total
score
two
senior
radiologist
evalu
score
chest
radiograph
independ
contribut
mean
total
radiograph
score
case
recognit
onset
day
diseas
mark
first
time
fever
report
patient
confirm
measur
calcul
steroid
dose
corticosteroid
therapi
studi
includ
aggress
treatment
critic
patient
rescu
regimen
worsen
case
dosag
steroid
calcul
week
onset
attempt
circumv
calcul
rescu
use
high
dosag
corticosteroid
death
patient
defin
rescu
use
corticosteroid
sudden
increas
dosag
week
onset
day
patient
die
way
calcul
abl
includ
total
dosag
corticosteroid
avoid
four
case
rescu
use
corticosteroid
daili
dosag
mg
methylprednisolon
methylprednisolon
major
steroid
use
patient
small
percentag
treat
hydroprednison
dexamethason
dose
convert
methylprednisolon
equival
mg
mg
methylprednisolon
mg
mg
methylprednisolon
recognit
complic
complic
studi
refer
occur
cours
treatment
associ
progress
sar
treatment
intervent
major
complic
includ
pneumothorax
mediastin
emphysema
myocardi
injuri
arrhythmia
hyperglycemia
high
bp
hypokalemia
secondari
lower
respiratori
extrapulmonari
infect
gi
tract
hemorrhag
recognit
secondari
lower
respiratori
infect
secondari
lower
respiratori
infect
sar
patient
recogn
one
follow
met
histolog
evid
bacteri
fungal
infect
lung
present
pneumonia
pathogen
isol
blood
pleural
effus
ident
result
sputum
cultur
week
time
cours
sar
condit
resolut
fever
signific
clinic
improv
obviou
resolut
chest
radiograph
recurr
fever
cough
sputum
well
newli
develop
lung
infiltr
chest
radiograph
observ
appar
purul
sputum
leukocytosi
confirm
pathogen
sputum
two
consecut
cultur
find
recognit
myocardi
injuri
myocardi
injuri
refer
one
time
increas
creatinin
kinasemb
recognit
extrapulmonari
infect
criteria
determin
secondari
extrapulmonari
infect
follow
bacteria
fungi
infect
site
lower
respiratori
tract
prove
patholog
isol
two
consecut
cultur
find
extrapulmonari
fluid
method
determin
baselin
valu
timedepend
variabl
patient
follow
steroidtr
patient
median
daili
record
valu
day
prior
hisher
first
steroid
dosag
nonsteroidtr
patient
median
daili
record
valu
day
prior
specif
day
median
length
time
diseas
onset
first
steroid
dosag
among
steroidtr
patient
definit
critic
sar
diagnosi
critic
sar
made
accord
criteria
sar
guidelin
issu
ministri
public
health
china
incorpor
low
oxygen
index
oi
mm
hg
word
sar
manifest
match
ali
diagnos
critic
sar
case
otherwis
deem
noncrit
statist
analysi
statist
softwar
spss
spss
chicago
il
employ
statist
analysi
measur
data
summar
mean
sd
analysi
varianc
test
use
univari
test
forward
stepwis
condit
logist
regress
cox
regress
use
multivari
analysi
primari
end
point
death
caus
sar
hospit
discharg
survivor
variabl
possibl
affect
primari
end
point
includ
univari
analysi
screen
potenti
confound
process
logist
regress
cox
regress
signific
level
univari
analysi
set
variabl
might
overlook
stage
use
steroid
evalu
relationship
case
fatal
hospit
day
signific
level
analysi
concern
hospit
day
surviv
case
use
avoid
confound
effect
death
noncrit
critic
case
among
enrol
sar
patient
gener
characterist
patient
shown
tabl
steroid
therapi
sar
patient
guangzhou
heterogen
noncrit
patient
critic
patient
receiv
steroid
time
initi
first
steroid
dosag
steroidtr
patient
day
diseas
onset
death
critic
sar
case
noncrit
patient
surviv
diseas
risk
factor
relat
death
day
hospit
analyz
candid
risk
factor
found
univari
analysi
comparison
noncrit
critic
case
survivor
death
critic
case
tabl
two
logist
regress
perform
death
complic
end
point
respect
use
steroid
well
abovement
potenti
confound
independ
variabl
regress
case
fatal
logist
regress
base
data
sar
case
death
yesno
end
point
show
signific
differ
case
fatal
steroidand
nonsteroidtr
patient
howev
result
logist
regress
base
data
critic
sar
case
show
steroid
therapi
significantli
reduc
case
fatal
among
critic
sar
patient
deathrel
variabl
adjust
age
rigor
onset
secondari
lower
respiratori
infect
pulmonari
rale
oi
grade
odd
ratio
case
fatal
steroidtr
patient
nonsteroidtr
patient
confid
interv
ci
tabl
logist
regress
base
data
sar
case
critic
sar
case
least
one
complic
yesno
end
point
show
signific
differ
complic
present
steroidand
nonsteroidtr
patient
adjust
invas
ventil
tabl
case
fatal
base
data
sar
case
cox
regress
death
yesno
end
point
fail
show
signific
differ
surviv
time
sinc
first
time
fever
two
group
howev
base
data
critic
sar
case
result
cox
regress
show
use
steroid
reduc
odd
case
fatal
among
critic
sar
patient
tabl
odd
case
fatal
among
steroidtr
patient
time
much
among
nonsteroidtr
patient
variabl
use
invas
ventil
age
adjust
tabl
effect
steroid
surviv
time
shown
figur
day
surviv
rate
among
steroidand
nonsteroidtr
patient
respect
hospit
discharg
base
data
survivor
case
among
sar
case
analysi
hospit
day
survivor
cox
regress
show
signific
differ
patient
receiv
steroid
howev
base
data
survivor
case
among
critic
sar
case
result
cox
regress
show
number
hospit
day
reduc
steroid
therapi
variabl
complic
present
adjust
odd
earlier
discharg
among
steroidtr
patient
ci
odd
discharg
among
nonsteroidtr
patient
tabl
effect
steroid
hospit
day
shown
figur
new
emerg
infecti
sever
respiratori
diseas
diagnosi
manag
sar
attract
much
attent
mani
public
diagnosi
manag
previou
report
use
clinic
orient
criteria
case
identif
specif
prone
overdiagnosi
posit
rate
convalesc
antibodi
report
tian
et
al
gao
et
al
studi
patient
healthcar
worker
definit
contact
histori
typic
present
chen
abl
show
seroconvers
fourfold
rise
serum
sarsigg
convalesc
phase
abovement
inform
suggest
diagnosi
sar
base
clinic
inform
alon
might
caus
overdiagnosi
studi
review
case
confirm
virolog
avoid
bia
inclus
unconfirm
case
sinc
sarsspecif
treatment
develop
manag
diseas
remain
clinic
base
support
importantli
acut
respiratori
failur
typic
seen
late
phase
critic
sar
mainli
present
dyspnea
hypoxia
meet
diagnost
criteria
ali
reason
steroid
therapi
critic
sar
becom
focu
interest
report
clinic
experi
expert
panel
guangzhou
sever
report
steroid
therapi
critic
sar
also
lack
controversi
outcom
usag
ho
et
al
compar
case
receiv
highdos
puls
methylprednisolon
therapi
ie
mgd
consecut
day
taper
mgd
total
cours
day
case
receiv
lowdos
nonpuls
corticosteroid
equival
approxim
mgkgd
methylprednisolon
therapi
report
patient
receiv
highdos
puls
corticosteroid
less
oxygen
requir
better
radiograph
outcom
less
likelihood
requir
subsequ
highdos
puls
corticosteroid
therapi
counterpart
signific
differ
two
group
sever
secondari
infect
howev
studi
ho
et
al
control
receiv
corticosteroid
group
zhao
colleagu
compar
clinic
outcom
four
treatment
protocol
case
sar
tabl
expans
abbrevi
suggest
basi
antibiot
antivir
ribavirin
recombin
earli
highdosag
steroid
mgd
methylprednisolon
result
best
outcom
death
compar
lowdos
steroid
therapi
howev
random
control
studi
patient
admit
differ
period
receiv
differ
treatment
protocol
major
confound
affect
outcom
sar
adjust
multivari
analysi
studi
meng
et
al
indic
earli
administr
steroid
help
symptom
reliev
pulmonari
resolut
shown
lowdos
methylprednisolon
mgd
associ
significantli
shorter
hospit
day
vs
highdos
drug
mgd
sung
et
al
report
outcom
stepwis
treatment
protocol
steroid
administr
treatment
sar
hong
kong
initi
treatment
broadspectrum
antibiot
combin
ribavirin
lowdos
corticosteroid
tabl
tabl
expans
abbrevi
nevertheless
also
opposit
opinion
data
li
et
al
show
highdos
steroid
deterior
low
level
give
rise
sever
secondari
infect
lee
et
al
report
effect
steroid
therapi
sarscov
load
serial
plasma
sarscov
rna
concentr
measur
use
onestep
realtim
revers
transcriptasepcr
assay
target
nucleocapsid
gene
found
plasma
sarscov
rna
concentr
second
third
week
ill
significantli
higher
patient
receiv
initi
hydrocortison
treatment
n
compar
receiv
placebo
n
area
curv
mannwhitney
p
increas
mortal
associ
highdos
steroid
also
implic
tsang
et
al
variabl
result
studi
may
lie
sever
reason
first
case
abovement
articl
seroneg
sarsigg
respons
bia
due
overdiagnosi
studi
regist
case
guangzhou
fulfil
criteria
case
identif
institut
world
health
organ
second
match
sar
case
strictli
control
studi
shown
present
studi
noncrit
sar
associ
mortal
patient
receiv
steroid
therapi
mix
noncrit
critic
sar
inform
togeth
would
interfer
abil
statist
analysi
evalu
effect
steroid
mortal
might
reason
steroid
show
efficaci
mortal
sar
patient
whole
significantli
effect
critic
tabl
cum
cumul
sar
third
adjust
confound
crucial
minim
effect
incompar
baselin
condit
present
studi
much
attent
paid
adjust
baselin
condit
import
confound
adjust
confound
multivari
analysi
shown
proper
use
steroid
result
less
fatal
lower
instant
mortal
fewer
hospit
day
mechan
corticosteroid
manag
sar
unclear
clinic
manifest
diagnosi
criteria
critic
sar
larg
ident
ali
differ
critic
sar
definit
caus
sarscov
infect
wherea
ali
may
result
varieti
etiolog
includ
infect
noninfect
mechan
corticosteroid
critic
sar
might
share
similar
aliard
ard
excess
system
inflamm
document
nuclear
factorb
may
respons
glucosteroid
resist
lead
rel
adren
insuffici
subsequ
aggrav
ard
replac
exogen
methylprednisolon
may
reliev
symptom
amelior
system
inflamm
therefor
current
opinion
hold
steroid
therapi
ard
given
basi
rel
adren
insuffici
induc
system
inflamm
orient
suppress
system
inflamm
durat
steroid
depend
length
inflamm
word
proper
guidelin
steroid
administr
aliard
includ
initi
appropri
dose
steroid
time
rel
adren
insuffici
reflect
studi
term
steroid
use
howev
steroid
delay
ard
fulli
develop
advanc
ard
appar
sever
patholog
set
back
efficaci
steroid
cohort
studi
peiri
et
al
found
view
viral
replic
inflammatori
respons
clinic
progress
sar
present
triphas
pattern
earli
phase
character
system
symptom
relat
effect
viral
replic
diseas
progress
midphas
system
inflammatori
respons
syndrom
becam
promin
give
rise
system
inflammatori
respons
syndromeinduc
lung
injuri
ali
ard
mani
complic
late
phase
note
time
igg
seroconvers
start
day
seem
correl
fall
viral
shed
nasopharynx
sever
clinic
worsen
also
occur
time
possibl
relat
immunopatholog
damag
presenc
immunopatholog
damag
confirm
jiang
et
al
studi
interferoninduc
protein
markedli
elev
blood
earli
stage
sar
remain
high
level
convalesc
moreov
highli
express
lung
lymphoid
tissu
monocytemacrophag
infiltr
deplet
lymphocyt
observ
clinic
worsen
midphas
sar
may
result
immunopatholog
damag
due
overexuber
host
respons
reduc
steroid
recent
studi
cytokin
profil
sar
patient
mark
elev
thelper
type
cytokin
inflammatori
cytokin
interleukin
il
il
il
show
least
week
diseas
onset
corticosteroid
reduc
significantli
monocyt
chemoattract
concentr
day
treatment
confirm
activ
thelper
type
cellmedi
immun
sar
accumul
monocytesmacrophag
neutrophil
anoth
studi
tumor
necrosi
higher
normal
treatment
corticosteroid
treatment
result
fall
tumor
necrosi
data
suggest
steroid
therapi
show
advantag
reduc
inflammatori
respons
protect
lung
injuri
well
known
corticosteroid
therapi
doubleedg
sword
point
studi
lee
et
al
earli
corticosteroid
treatment
might
associ
higher
subsequ
plasma
viral
load
data
publish
far
show
benefit
corticosteroid
sar
earli
phase
sarscov
replic
ongo
evid
lopsid
wish
use
steroid
sar
earli
possibl
also
highdos
administr
regardless
sever
diseas
exact
mechan
steroid
therapi
elucid
potenti
benefit
steroid
therapi
critic
sar
includ
improv
pulmonari
oxygen
reduc
need
intub
case
fatal
pulmonari
fibrosi
howev
studi
reveal
reduc
fatal
shorter
hospit
stay
critic
sar
fail
demonstr
advantag
relat
steroid
administr
futur
studi
need
elucid
effect
use
anim
model
random
prospect
casecontrol
clinic
trial
advers
effect
steroid
acknowledg
elsewher
includ
hyperglycemia
high
bp
hypokalemia
immunocompromis
superinfect
effect
depend
variou
factor
ie
underli
diseas
age
sever
intervent
well
dose
durat
steroid
studi
secondari
infect
sar
shown
relat
employ
invas
ventil
statist
relat
use
steroid
nevertheless
monitor
prevent
secondari
infect
complic
strictli
indic
steroid
therapi
anoth
notic
problem
steroid
lie
relationship
avascular
osteonecrosi
avn
sar
convalesc
cluster
sampl
survey
healthcar
worker
four
hospit
guangzhou
shen
et
al
found
rate
avn
case
much
lower
report
correl
maxim
singleday
dose
steroid
low
incid
avn
sar
case
guangzhou
may
relat
compar
low
dose
short
durat
steroid
use
region
addit
steroid
fatal
critic
sar
may
affect
mani
relev
factor
multivari
analysi
studi
show
elder
age
rigor
onset
secondari
lower
respiratori
infect
pulmonari
rale
use
invas
ventil
relat
higher
fatal
contribut
invas
ventil
increas
fatal
may
aris
increas
rate
complic
seriou
condit
per
se
conclus
retrospect
studi
guangzhou
sar
case
demonstr
less
fatal
shorter
hospit
day
signific
effect
lower
respiratori
infect
confirm
critic
sar
patient
corticosteroid
administ
properli
find
support
ration
use
steroid
critic
sar
oi
mm
hg
